Oruka Therapeutics, Inc. Common Stock logo

Oruka Therapeutics, Inc. Common Stock (ORKA) Technical Analysis

$60.14-3.44%

Market is closed - opens 7 PM, 08 Jun 2026

Insights

  • Oruka Therapeutics Common Stock is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Oruka Therapeutics Common Stock stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Oruka Therapeutics Common Stock stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Oruka Therapeutics Common Stock stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
49.88
Neutral
Stochastic
63.3, 60.01
Neutral
Ultimate Oscillator
50.38
Neutral
Stochastic Relative Strength Index
72.14, 45.66
Neutral
Moving Average Convergence Divergence
-0.99, -0.89
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
58.4
Sell
20
60.16
Sell
50
61.73
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
59.03
Sell
20
60.04
Buy
50
57.96
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
58.58
Neutral
20
59.97
Neutral
50
64.63
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
58.33
Sell
20
58.76
Sell
50
64.93
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
59.26
Buy
20
56.58
Sell
50
63.04
Sell

Pivot

Pivot

Value

Resistance L3
70.87
Resistance L2
67.23
Resistance L1
64.75
Pivot Point
61.11
Support L1
58.63
Support L2
54.99
Support L3
52.51

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.